$KVUE

Howlett Heather sold $67K of KVUE

Howlett Heather (CFO & CAO) sold 3,700 shares of Kenvue Inc. (KVUE) at $18.10 on 2026-06-10.

Original reporting
SEC EDGAR · Howlett Heather
Published Jun 12, 2026, 8:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 12, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KVUE
Neutral
high confidence
Mentioned
$KVUE
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KVUENeutralLow
01

Why it matters

The disclosure updates the record of insider ownership after an open-market sale; it does not include guidance, litigation, product, or financial performance changes.

02

Market read

Traders may note the insider sale for sentiment, but there is no new fundamental catalyst in the text.

03

What to watch

The article does not state whether the sale was part of a 10b5-1 plan (it says 'No'), but it also provides no context on compensation, tax obligations, or prior trading patterns.

Relevance 3/10Novelty 2/10Timing: Filed 2026-06-12; sale executed 2026-06-10.

Background

The article summarizes an SEC Form 4 insider transaction for Kenvue (KVUE) by CFO & CAO Howlett Heather.

Company-level read

Ticker impact

$KVUENeutralHigh confidence
Context

Kenvue CFO & CAO Howlett Heather sold 3,700 KVUE shares in an open-market transaction on 2026-06-10 (Form 4).

Expected impact

Low near-term impact; any effect is likely sentiment-only and outweighed by normal trading noise.

Evidence & confidence

The filing is a disclosed insider sale (not a buy), but it is small in absolute terms and provides no new company-specific operational or financial catalyst.

Market effects

No clear sector read-through; this is company-specific insider transaction data.

None.

None.

Counterpoint

Insider sales can be driven by diversification, taxes, or scheduled liquidity needs rather than bearish fundamentals—especially when not tied to a new negative event.

Key entities

  • Howlett Heather

    CFO & CAO of Kenvue; sold 3,700 shares via open-market sale.

  • Kenvue Inc.

    Issuer of KVUE shares; insider sale disclosed on SEC EDGAR.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KMBHighAI 9/10

Kimberly-Clark Moves to Clear EU Hurdle with Kenvue Asset Sales

Kimberly-Clark (KMB) is selling assets to address EU antitrust concerns over its $40B Kenvue acquisition, aiming for approval by September 29. The deal, expected to create a $32B revenue company, faces similar scrutiny in Australia. KMB anticipates $1.9B in annual cost synergies but may need to divest assets to secure approval.

$KVUEMedAI 9/10

Clark Eyes Asset Sales to Secure EU Nod for Kenvue Deal

Kimberly-Clark (KMB) is preparing asset sales to address EU antitrust concerns over its $40B acquisition of Kenvue (KVUE). The EU is expected to formally raise concerns this week. Shares of both companies rose on the news. The deal, announced last November, would expand Kimberly-Clark's product portfolio. The EU has until September 29 for a preliminary review.

$KVUEMedAI 8/10

Here's My Pick for the Smartest High-Yield Dividend Stock to Buy Right Now

Kenvue (KVUE) is highlighted as a strong high-yield dividend stock with a 4.68% yield and 64 years of consecutive dividend increases. Its stable of well-known brands reported Q2 revenue of $3.95B and EPS of $0.24. The company is being acquired by Kimberly-Clark (KMB), another Dividend King, which may create uncertainty about Kenvue's dividend.

$KMBHighAI 9/10

Exclusive-Kimberly-Clark prepares asset sales to win EU nod for Kenvue deal, sources say

Kimberly-Clark is preparing asset sales to address EU antitrust concerns regarding its $40 billion acquisition of Kenvue. The European Commission is expected to formally raise its concerns this week. Kimberly-Clark shares rose 2.7% and Kenvue gained 2.3% on the news. The deal, announced in November, would expand Kimberly-Clark's product range to include Kenvue's brands like Listerine, Aveeno, and Neutrogena.

$KMBHighAI 9/10

Exclusive-Kimberly-Clark readies asset sales in bid for EU nod for Kenvue deal, sources say

Kimberly-Clark (KMB) is preparing asset sales to address EU antitrust concerns regarding its $40 billion acquisition of Kenvue. The EU is expected to formally raise its concerns this week, with Kimberly-Clark facing a September 29 deadline to submit concessions or face a full investigation. The deal has already received conditional approval in Australia and South Africa.